Omers Administration Corp Amgen Inc Transaction History

Omers Administration Corp

$10.4 Billion
Q3 2024

A detailed history of Omers Administration Corp transactions in Amgen Inc stock. As of the latest transaction made, Omers Administration Corp holds 21,461 shares of AMGN stock, worth $5.65 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

21,461

Previous 22,361 4.02%

Holding current value

$5.65 Million

Previous $6.99 Million 1.03%

% of portfolio

0.07%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $278,442 - $303,642	-900 Reduced 4.02%	21,461 $6.91 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $5.88 Million - $7.14 Million	22,361 New	22,361 $6.99 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $5.15 Million - $6.83 Million	-28,251 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $4.1 Million - $5.27 Million	-21,661 Reduced 43.4%	28,251 $6.81 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.43 Million - $1.71 Million	8,200 Added 19.66%	49,912 $9.66 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $6.05 Million - $7.1 Million	36,312 Added 672.44%	41,712 $7.79 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $976,698 - $1.1 Million	5,400 New	5,400 $1.06 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $6.85 Million - $8 Million	-38,412 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $37,058 - $41,778	200 Added 0.52%	38,412 $7.96 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $763,830 - $857,946	4,600 Added 13.69%	38,212 $7.05 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $595,038 - $695,376	3,512 Added 11.67%	33,612 $5.73 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $5.08 Million - $5.68 Million	30,100	30,100 $5.23 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.

Account

Omers Administration Corp Amgen Inc Transaction History